3460-11-5Relevant articles and documents
Amidation of aryl halides catalyzed by silica-supported bidentate phosphine palladium complex
Cai, Ming-Zhong,Song, Cai-Sheng,Huang, Xian
, p. 361 - 366 (1997)
A silica-supported bidentate phosphine palladium complex was prepared from poly-4-oxa-6,7-bis(diphenylphosphino)heptyl siloxane and palladium chloride in acetone. It was an efficient catalyst for the amidation of aryl halides with carbon monoxide and aniline at 1 atm pressure, affording aryl amides.
Cyclic hydroxamic acids as oxygenating agents - Conversion of imines to anilides
Sahadeva Reddy,Pratap Reddy,Reddy
, p. 3447 - 3451 (2001)
Cyclic hydroxamic acid mediated functional group modification of an imine to anilide is reported.
Optimizing the structure of (salicylideneamino)benzoic acids: Towards selective antifungal and anti-staphylococcal agents
Krátky, Martin,Kone?ná, Klára,Broke?ová, Kate?ina,Maixnerová, Jana,Trejtnar, Franti?ek,Vin?ová, Jarmila
, (2021/02/03)
An increasing resistance of human pathogenic bacteria and fungi has become a global health problem. Based on previous reports of 4-(salicylideneamino)benzoic acids, we designed, synthesised and evaluated their me-too analogues as potential antimicrobial agents. Forty imines derived from substituted salicylaldehydes and aminobenzoic acids, 4-aminobenzoic acid esters and 4-amino-N-phenylbenzamide were designed using molecular hybridization and prodrug strategies. The target compounds were synthesized with high yields and characterized by spectral methods. They were investigated against a panel of Gram-positive and Gram-negative bacteria, mycobacteria, yeasts and moulds. The most active imines were tested to determine their cytotoxicity and selectivity in HepG2 cells. Dihalogenosalicylaldehydes-based derivatives showed potent broad-spectrum antimicrobial properties, particularly against Gram-positive bacteria including methicillin-resistant Staphylococcus aureus (minimum inhibitory concentrations, MIC, from 7.81 μM) and Enterococcus faecalis (MIC of ≥15.62 μM), yeasts (MIC from 7.81 μM) and Trichophyton interdigitale mould (MIC of ≥3.90 μM). Methyl 4-[(2-hydroxy-3,5-diiodobenzylidene)amino]benzoate 4h exhibited excellent in vitro activity along with low toxicity to mammalian cells. This compound is selective for staphylococci, Candida spp. and Trichophyton interdigitale. In addition, this imine was evaluated as a potential inhibitor of Gram-positive biofilms. The successful approach used provided some promising derivatives with more advantageous properties than the parent 4-(salicylideneamino)benzoic acids.
HDAC/MIF dual inhibitor inhibits NSCLC cell survival and proliferation by blocking the AKT pathway
Cao, Fangyuan,Chen, Deng,Chen, Siwei,Dekker, Frank J.,Haisma, Hidde J.,Xiao, Zhangping,Zhao, Chunlong
, (2021/10/19)
Non-small-cell lung carcinoma (NSCLC) is one of the most common forms of lung cancer, and a leading cause of cancer death among human beings. There is an urgent demand for novel therapeutics for the treatment of NSCLC to enhance the efficacy of the currently applied Tyrosine kinase inhibitors (TKIs) therapy and to overcome therapy-resistance. Here, we report a novel small-molecule inhibitor that simultaneously targets histone deacetylase (HDAC) and macrophage migration inhibitory factor (MIF). The HDAC/MIF dual inhibitor proved to be toxic for EGFR mutated (H1650, TKI-resistant) or knock out (A549 EGFR?/?) NSCLC cell lines. Further experiments showed that HDAC inhibition inhibits cell survival and proliferation, while MIF inhibition downregulates pAKT or AKT expression level, which both interfere with cell survival. Furthermore, the combination treatment of TKI and HDAC/MIF dual inhibitor showed that the dual inhibitor enhanced TKI inhibitory efficacy, highlighting the advantages of HDAC/MIF dual inhibitor for more effective treatment of NSCLC.